A detailed history of Iron Financial, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Iron Financial, LLC holds 9,901 shares of GILD stock, worth $934,753. This represents 0.46% of its overall portfolio holdings.

Number of Shares
9,901
Holding current value
$934,753
% of portfolio
0.46%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$66.59 - $83.99 $659,307 - $831,584
9,901 New
9,901 $829,000
Q4 2020

Jan 13, 2021

SELL
$56.65 - $64.55 $217,705 - $248,065
-3,843 Closed
0 $0
Q3 2020

Nov 09, 2020

BUY
$62.1 - $78.08 $238,650 - $300,061
3,843 New
3,843 $243,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Iron Financial, LLC Portfolio

Follow Iron Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iron Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iron Financial, LLC with notifications on news.